CA1322133C - Process for producing microcapsules - Google Patents
Process for producing microcapsulesInfo
- Publication number
- CA1322133C CA1322133C CA000587965A CA587965A CA1322133C CA 1322133 C CA1322133 C CA 1322133C CA 000587965 A CA000587965 A CA 000587965A CA 587965 A CA587965 A CA 587965A CA 1322133 C CA1322133 C CA 1322133C
- Authority
- CA
- Canada
- Prior art keywords
- microcapsules
- gelatin
- coacervates
- hardening
- core material
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003094 microcapsule Substances 0.000 title claims abstract description 51
- 238000000034 method Methods 0.000 title claims abstract description 30
- 230000008569 process Effects 0.000 title claims abstract description 23
- 108010010803 Gelatin Proteins 0.000 claims abstract description 35
- 239000008273 gelatin Substances 0.000 claims abstract description 34
- 229920000159 gelatin Polymers 0.000 claims abstract description 34
- 235000019322 gelatine Nutrition 0.000 claims abstract description 34
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 34
- 150000001875 compounds Chemical class 0.000 claims abstract description 20
- 239000000126 substance Substances 0.000 claims abstract description 10
- 238000004132 cross linking Methods 0.000 claims abstract description 8
- 239000011162 core material Substances 0.000 claims description 18
- AZKVWQKMDGGDSV-BCMRRPTOSA-N Genipin Chemical compound COC(=O)C1=CO[C@@H](O)[C@@H]2C(CO)=CC[C@H]12 AZKVWQKMDGGDSV-BCMRRPTOSA-N 0.000 claims description 11
- AZKVWQKMDGGDSV-UHFFFAOYSA-N genipin Natural products COC(=O)C1=COC(O)C2C(CO)=CCC12 AZKVWQKMDGGDSV-UHFFFAOYSA-N 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 8
- 238000005354 coacervation Methods 0.000 claims description 7
- 125000000129 anionic group Chemical group 0.000 claims description 5
- 230000006872 improvement Effects 0.000 claims description 4
- 229920006318 anionic polymer Polymers 0.000 abstract description 9
- 239000002245 particle Substances 0.000 abstract description 5
- 239000007787 solid Substances 0.000 abstract description 4
- 229920000642 polymer Polymers 0.000 abstract description 2
- 238000005054 agglomeration Methods 0.000 description 12
- 230000002776 aggregation Effects 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 239000004848 polyfunctional curative Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 5
- 235000013305 food Nutrition 0.000 description 4
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 3
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 3
- 239000001263 FEMA 3042 Substances 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 235000012209 glucono delta-lactone Nutrition 0.000 description 3
- 239000000182 glucono-delta-lactone Substances 0.000 description 3
- 229960003681 gluconolactone Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 3
- 229940033123 tannic acid Drugs 0.000 description 3
- 235000015523 tannic acid Nutrition 0.000 description 3
- 229920002258 tannic acid Polymers 0.000 description 3
- 244000215068 Acacia senegal Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- 235000018958 Gardenia augusta Nutrition 0.000 description 2
- 240000001972 Gardenia jasminoides Species 0.000 description 2
- 229920000084 Gum arabic Polymers 0.000 description 2
- 235000010489 acacia gum Nutrition 0.000 description 2
- 239000000205 acacia gum Substances 0.000 description 2
- 229940037003 alum Drugs 0.000 description 2
- 235000011126 aluminium potassium sulphate Nutrition 0.000 description 2
- 230000000703 anti-shock Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- KOWWOODYPWDWOJ-LVBPXUMQSA-N elatine Chemical compound C([C@]12CN(C3[C@@]45OCO[C@]44[C@H]6[C@@H](OC)[C@@H]([C@H](C4)OC)C[C@H]6[C@@]3([C@@H]1[C@@H]5OC)[C@@H](OC)CC2)CC)OC(=O)C1=CC=CC=C1N1C(=O)CC(C)C1=O KOWWOODYPWDWOJ-LVBPXUMQSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229940050271 potassium alum Drugs 0.000 description 2
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- 241000237074 Centris Species 0.000 description 1
- XJMPAUZQVRGFRE-SCHFUKFYSA-N Gardenoside Natural products O=C(OC)C=1[C@H]2[C@H]([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)[C@@](O)(CO)C=C2 XJMPAUZQVRGFRE-SCHFUKFYSA-N 0.000 description 1
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 1
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 1
- ZJDOESGVOWAULF-OGJQONSISA-N Geniposidic acid Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@@H]2C(CO)=CC[C@@H]2C(C(O)=O)=CO1 ZJDOESGVOWAULF-OGJQONSISA-N 0.000 description 1
- VYAALAFRWREWLA-BVTMAQQCSA-N Geniposidic acid Natural products CCC1=CC[C@H]2[C@@H]1[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C2C(=O)O VYAALAFRWREWLA-BVTMAQQCSA-N 0.000 description 1
- ZJDOESGVOWAULF-UHFFFAOYSA-N Geniposidinsaeure Natural products OC1C(O)C(O)C(CO)OC1OC1C2C(CO)=CCC2C(C(O)=O)=CO1 ZJDOESGVOWAULF-UHFFFAOYSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- BZPMXJKRKXDRID-UOIKKKDVSA-N Scandoside Natural products OC[C@H]1O[C@@H](O[C@H]2CC=C([C@@H]3[C@@H](O)C=C(CO)[C@H]23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O BZPMXJKRKXDRID-UOIKKKDVSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003028 elevating effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- XJMPAUZQVRGFRE-AYDWLWLASA-N methyl (1s,4as,7s,7as)-7-hydroxy-7-(hydroxymethyl)-1-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1h-cyclopenta[c]pyran-4-carboxylate Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1[C@](C=C2)(O)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O XJMPAUZQVRGFRE-AYDWLWLASA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000007967 peppermint flavor Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000004886 process control Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000021487 ready-to-eat food Nutrition 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/06—Making microcapsules or microballoons by phase separation
- B01J13/10—Complex coacervation, i.e. interaction of oppositely charged particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
- B01J13/02—Making microcapsules or microballoons
- B01J13/20—After-treatment of capsule walls, e.g. hardening
- B01J13/206—Hardening; drying
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- General Preparation And Processing Of Foods (AREA)
- Jellies, Jams, And Syrups (AREA)
- Formation And Processing Of Food Products (AREA)
- Medicinal Preparation (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Abstract
PROCESS FOR PRODUCING MICROCAPSULES
Abstract of the Disclosure A process for producing microcapsules which comprises forming a wall of coacervates on microdroplets of an oily substance or water-insoluble solid particles through reaction between gelatin and an anionic polymer, allowing a iridoid compound to act on the coacervates so that cross-linking occurs between the polymer molecules of gelatin to harden the microcapsules.
Abstract of the Disclosure A process for producing microcapsules which comprises forming a wall of coacervates on microdroplets of an oily substance or water-insoluble solid particles through reaction between gelatin and an anionic polymer, allowing a iridoid compound to act on the coacervates so that cross-linking occurs between the polymer molecules of gelatin to harden the microcapsules.
Description
`- ~3æ2~33 PROCESS FOR PRODUCING MICROCAPSULES
Background of the Invention The present invention relates to the production of microcapsules containing as the core material oily substances or water-insoluble solid particles. More particularly, the present inVention relates to a process for producing microcapsules which comprises forming a wall of coacervates on microdroplets of an oily substance or water-insoluble solid particles through reaction between gelatin and an anionic polymer, and allowing a iridoid compound to act on the coacervates so that cross-linking occurs between the polymer molecules of gelatin to harden the microcapsules.
Microcapsules which are tiny particles of a core material surrounded by a coating Consisting of a wall material such as gelatin serve to protect the core material from its surroundings by means of the wall membrane, or to control the time, place or rate at which the core material is released. Having these capabilities, microcapsules have 2Q been extensively used in pressure-sensitive copy paper, foodstuffs, pharmaceuticals and in many other fields of industry.
One of the com~on methods for producing microcapsules is "complex coacervationt' which is commercially the most common for pressure-sensitive copy paper. In this process, two colloidal substances, such as gelatin and an anionic polymeric substance, having mutually opposite electric charges, are added to a cor~-containing sUspens ~ ~orm , ..
~,: - 1 --, : .: :-: :, ~. ,:, - : -. ~ . . . ,, ;: , -.: . , ,,,- , : , ~322133 an aqueous sol, which is then pH-adjusted or otherwise treated to form a wall of coacervates on the microdroplets of an oily core material, and after they have gelled the coacervates are hardened with a hardening agent to form microcapsules. Details of this complex coacervation process are disclosed in U.S. Patent No. 2,800,457, etc. and many methods of improvement have been proposed.
For instance, Japanese Patent Publication No. 39-24782 proposes that the temperature of the system be slowly elevated in the presence of a hardening reagent in order to shorten the duration of the hardening treatment. Japanese Patent Publication Nos. 47-16166, 47-16167 and 47-16168 propose that in order to prevent agglomeration of coacer-vates, an anti-shock agent be added after the wall membrane of coacervates has been gelled. Japanese Patent Publica-tion Nos~ 50-27827, 50-27828 and 50-27829 show that by adding an anti-shock agent such as CMC or an acrylic acid copolymer together with an anionic surfactant, it is possible to prevent any increase in viscosity that would otherwise occur on account of the reaction taking place between gelatin and aldehyde during the pre-hardening step. Japanese Patent Public Disclosure No. 61-4527 discloses a method in which a water-soluble wax derivative is added after gelation and before hardening. Methods employing hardening agents that may be added to foods are disclosed in Japanese Patent Public Disclosure ~os. 59-36540, 60-37934, 61-4527, 61-78351, etc.
-, . .:
~322133 As described above, numerous improvements have been developed in the technology of microencapsulation by complex coacervation. However, there still remains much room for improvement in the art of hardening coacervates. For 5 example, no process has yet been developed for producing ;~
mi.crocapsules employing a hardening a~ent which can be safely incorporated in foodstuffs, which is stable, and -which allows the hardening treatment to be effected within a short period. Hardening agents that are most commonly employed in the conventional techniques of complex coacerva-tion are aldehydes such as formaldehyde and glutaraldeh~de.
~owever, aldehydes are toxic and cannot be used in the production of mlcrocapsules to be incorporated in foodstuffs.
A further problem with the use of aldehydes as hardeners is tha~t the pH of~the system has to be adjusted to the alkali s~ide~in order to~increase the rate of hardening reaction. Unless utmost cars ~lS exerclsed in the pH
adjustment, agglomeration of coacervates and other troubles wiIl occur to increase the~complexity of process control.
Hardeners that have been employed in the production of microcapsules for~incorporation in foodstuffs include .
glucono delta lactone, tannic acid, potassium alum [KAl(S 04 ) 2 12H20] and arnrnonium alum [NH4Al(SO4)2 12H~O].
Glucono delta lactone and~tannic acid harden gelatin by causing acid denaturation of the gelatin~protein, and the alum compounds achieve the same result by binding between the molecules of gelatin protein. However, all of these - 1`3-2`27~`3 3 hardeners are slow in their hardening rate because their action is weaker than that of aldehydes. If the reaction temperature is raised in an attempt of increase the hardening rate, the chance coacervates of being broken is increased. Under these circumstances, the hardening reaction must be carried out over a prolonged period ~usually several tens of hours) at room temperature.
Furthermore, the ~Yall membrane of the resulting capsules is weak and has insufficient heat resistance.
Summary of the Invention The present invention has been accomplished in order to solve the aforementioned problems of the prior art and its principal object is to ~rovide a method of hardening coacervates in the production of microcapsules i) in a pH
range that will not cause a~glomeration of the coacervates ii) within a short period of time iii) without employing any harmful component that cannot be incorporated in foodstuffs and by which iv)~microcapsules having high physical strength and heat resistance can be obtained.
This object of the present invention can be attained by a process for produclng microcapsules by complex coacervation of an aqueous solution of gelatin and an anionic polymeric substance having a core material present in an emulsified or dispersed state, ~Yhich is characteri~ed in that the gelatin in the wall membrane of coacervates formed around the microdroplets o~ the core material is hardened by crosslinking reaction ~ith a iridoid compound so as to produce microcapsules.
,:
`- i3221~3 Detailed Description of the Invention The present inventors found that iridoid compounds, in particular genipin, are a very effective hardeners for use in the production of microcapsules having a gelatin wall S membrane.
The present invention provides a process for producing microcapsules b~r complex coacervation o-f an aqueous solution of ~elatin and an anionic polymeric substance having a core material present in an emulsified or dispersed state, ~hich is characterized in that the gelatin in the wall membrane of coacervates formed around the microdroplets of the core material is hardened by crosslinking reaction wlth a ilidoid compound so as to produce microcapsules.
The first step of the process of the present invention is to have the core material emulsified or dlspersed in an aqueous solution containing gelatin and an anionic polymer. This may be accomplished b~ mixing an aqueous solution of an anionic polymer with an aqueous gelatin solution that has the core material emulsified or dispersed in it. Alternatively? the core material emulsified or dispersed in the aqueous solution of an anionic polymer may be mixed with the aqueous gelatin solution. Still another approach is to have the core material emulsified or dispersed in an aqueous solution containin~ gelatin and an anionic polymer. In short, the first step o~ the process of the present invention is satisfactorily performed if the core material is emulsified :.: ., . : :~ :
~ ~ , :. :-, . ..
: . :: , - . :
~322~
or dispersed in an aqueous solution containing gelatin and an anionic polymer.
A suitable core material may be selected from among oily substances such as flavor oils and lecithin, and from water-insoluble solid particles such as stearyl alcohol.
There is no particular limitation on the gelatin that can be used but it is preferable to use gelatin having good physicochemical and chemical properties as typi-fied by good film-forming ability, the nature of an ampholyte, the controllability of the quantity of charges by pH, and the occurrence of the change from sol to gel at a critical temperature. Stated specifically, any gelatin that satisfies the specifications for use in the production of a certain microcapsule may be employed. More preferably, gelatin ha~ing an isoelectric point of pH ~ - 9 and a bloom strength of 280 - 320 is used.
Any anionic polymer that reacts with gelatin to ~orm complex coacervates may be employed and preferred examples include gum arabic, sodium alginate, agar, carrageenan, carboxymethyl cellulose, sodium polyacrylate, polyphosphoric acid, etc.
The mixture of gelatin and a suitable anionic polymer is diluted with war~ water; thereafter, an acidic aqueous solution such as acetic acid is added to reduce the pH of the system to the isoelectrie pOillt of gelatin or below, and the mixture is stirred with the temperature elevated at least to the gelling point of gelatin. In this step, coacervates will form. The p~ of the reaction system is :
1~2~3 normally reduced to between 4.0 and 5.0 but this condition need not be satisfied if the pH is no higher than the isoelectric point of the gelatin used. The temperature of the system is usuallY adjusted to be ~ithin the range of 45 - 55C.
The coacervates are then cooled to 20C or below to gel and are thereafter subjected to a hardening reaction.
What is important to the process of the present invention is that a iridoid compound is used as a hardening agent.
Stated more specifically, a iridoi~compound is added to a coacervate-containing slurry and the temperature of the system is slowly elevated to effect the hardenlng reaction.
In this step, the gelatin component o$ the coacervates is hardened to become water-insoluble, thereby completing the production of microcapsules having the core material conflned in the shell of coacervates.
Any i~idoid compound having a crosslinking ability may be used in the process of the present invention and illustrative examples are the a~lycones of geniposide, gardenoside, geniposidic acid, etc. Of these compounds, genipin derived from Gardenia jasminoides Ellis which is the aglycone of genlposide is most preferred. These iridoid compounds may be prepared in accordance with the disclosures in Japanese Patent Publication r~O. 57-14781, Japanese Patent Public Disclosure~No. 61-47167, etc.
The amount of the lridoid compound to be used in the hardening reaction ranges from 0.001 to 1.0 part per part of gelatin on a dry weight basis. In accordance with the - . -`` ~322~33 process of the present invention, the amount of iridoid co~pound used may be adjusted to control the physical properties and heat stability of the microcapsules to be obtained, thereby making it possible to produce microcapsules of a desired strength.
The hardening reaction is preferably conducted at a pH of ~ - 10, more preferablY below 7 where agglomeration of coacervates will not easily ta~e place. One of the great advantage o-f the present invention is that the coacervates can be hardened within this preférred range of pH. The reaction temperature may be ~ithin the range of 5 - 60C.
Since the iridoid compounds have a comparatively strong cross-linking action, the intended hardening reaction can be accomplished without further eleva-ting the temperature. The re.action time varies with pH andAtemperature~ but a satisfactory hardening treatment can be performed by leaving the system to stand or stirring it for a period o~ 0.5 - 2 hours.
It has been reported that the iridoid compounds derived from Gardenia jasminoides Ellis which are used as hardeners in the process of the present invention react with primary amino compounds and are further polymerized under oxidizing conditions to form blue dyes (Japanese Patent Publication No. 57-14781 and Japanese Patent Public Disclosure No. 61-47167). The safety of the ~lue dyes thus formed has been widely recognized as a result of their extensive use as natural pigments in foods. Therefore, the microcapsules produced in the process of the present ~e:
~ , ,., . : ".
- :. , .~ - :, . , : - ,., :
, : . ~ ~. . , :,: , . . . .
. :,- : " :i , - :
1322~3'~
invention by crosslinking a iridold compound with complex coacervates of gelatin and an anionic pol~mer are also safe and are of particularly utility for use in foods, pharmaceuticals and other fields of industry.
s The following examples are provided for the purpose of further illustrating the present invention but are in no way to be taken as limiting.
ExamPle 1 ~;~
Peppermint oiI (9 g) was dispersed and emulsi-fied, with stirring, in 30 g of a 10% aqueous solution of ~elatin ~ype A) at 40C to form an oil-in-water~(0/W) emulsion. To the resulting emulsion, 30 g of a 10% aqueous gum arabic solution preheated to 40C was added with stirring. To the llquid mixture, 140 g of warm~water (40-C) was added, followed by addition of acetic acid to adJust the pH of the system to 4Ø The system was quickly quenched to 10C with -stirring. Thereafter. 3 g of genipin was added to~the system while at the same tlme, its~pH was adjusted to 6.0 with sodium hydroxide.~ Subsequently, a hardening treatment was conducted by raising the temperature of the system to 40C ~t a rate of 1C/min. The precipitated microcapsules were thoroughly washed with water to remove any uncrosslinked genipln and thereafter centrifuged for 10 minutes at 2,800 rpm to recover the microcapsules as~the final product.
Example 2 A cold (10C) microcapsule solution was prepared as .
in Example 1. To the system was added 3 g of genipin and ~, . ~ .
~` _ g _ .
~32~133 the resulting system having a pH of 4.0 was subjected to a hardening treatment for 18 hours at 20C under mild stirring. The precipitated microcapsules were washed thoroughly with water to remove any uncrosslinked genipin and thereafter centrifuged for 10 minutes at 2,800 rpm to recover the microcapsules as the final product.
ExamPle 3 Microcapsules were produced by the same procedures of microencapsulation as those adapted in Example 2 except that the amount of genipin was reduced to 0.3 g.
Example 4 Microcapsules were produced by the same procedures of microencapsulation as those adapted ln Example 2 except that the amount of genipin was further reduced to 0.03 g.
The microcapsules produced in Examples 1 - 4 were suitable for use as peppermint flavors in ready-to-eat foods.
Comparative ExamDle 1 ~
~ A cold (10C) microcapsule solution was prepared as in Example 1. Three grams of glucono delta lactone was added to the solution under stirring and a hardening treatment was then performed by mildly stirring the ~ixture at 20~C for 18 hours. The precipitated microcapsules were washed thoroughly with water and centri~uged at 2,800 rpm for 10 minutes to recover the microcapsules as the final product.
Comparative Example 2 - : : - -: :: . : . : . :. :
13221~3 Microcapsules were produced as in Comparative Example 1 except that 3 g of potassium alum was used as a hardener.
Comparative Example 3 Microcapsules were produced as in Comparative Example 1 except that 3 g of tannic acid was used as a hardener.
Comparative Test The microcapsules produced in Examples 1 - 4 and Comparative Examples 1 - 3 were dried, and 5 g of each sample was added to 100 ml of distilled water. The solution were heated at a rate of 1C/min and the temperature at which the wall of microcapsules in each sample thoroughly dissolved was measured. The results are shown in Table l;
the wall of the microcapsules in the samples of Examples 1 and 2 dlssolved at lOO C and that of the microcapsules in the sample of Example 3 dissolved at 80C; in contrast, wall dissolution occurred at 45C and below in the samples o-f Example 4 and Comparatlve Examples 1 - 3.
These results show that by h~ardenin~ coacervates with genipin, the heat resisitance of microcapsules was improved, the duration of hardening treatment was shortened (see Example 1), and the degree of heat resistance could be controlled by adjusting the~amount of genipin added.
Table 1 also shows the amount of agglomeration which occurred in the microcapsules of Examples 1 - 4 and Com-parative Examples 1 -~3 after centrifugation. No detectable agglomeration occurred in the samples produced in Examples 1 - 4, but the wall membranes of the capsules prepared in Comparative Examples 1 - 3 were so weak that they readily , 132~133 formed agglomeration materials. It is therefore clear that the hardening treatment ~ith genipin is also effective in improving the handling properties of microcapsules.
Table 1 Evaluation of the Heat Stability of Microcapsules and Their Agglomeration after Centrifu~ation Capsule melting Agglomeration of SamPle No~ _ temperature Cmicrocavsules 10Example 1 100 Comparative 15Example 1 35 ++
2 40 - +-~
3 45 +
-: No agglomeration +: Some agglomeration ~+: Extensive agglomeration The present invention pro~ides a process for producing microcapsules by complex coacervation using gelatin as at least one hydrophlic colloid. In this process, a iridoid compound having no human toxicit~ which can be safely incorporated in foodstuffs is used as a hardener for coacervates. Besides the advantage o-f rapidity of treatment, the iridoid compound is capable of hardening coacervates with reduced agglomeration, thereby enabling the desired microcapsules to be produced easily and efficiently.
If desired, an appropriate degree of heat resistance can be imparted to the microcapsules, so they have potential use in a wide range of applications including the food and pharmaceutical industries.
~ : , . ...
Background of the Invention The present invention relates to the production of microcapsules containing as the core material oily substances or water-insoluble solid particles. More particularly, the present inVention relates to a process for producing microcapsules which comprises forming a wall of coacervates on microdroplets of an oily substance or water-insoluble solid particles through reaction between gelatin and an anionic polymer, and allowing a iridoid compound to act on the coacervates so that cross-linking occurs between the polymer molecules of gelatin to harden the microcapsules.
Microcapsules which are tiny particles of a core material surrounded by a coating Consisting of a wall material such as gelatin serve to protect the core material from its surroundings by means of the wall membrane, or to control the time, place or rate at which the core material is released. Having these capabilities, microcapsules have 2Q been extensively used in pressure-sensitive copy paper, foodstuffs, pharmaceuticals and in many other fields of industry.
One of the com~on methods for producing microcapsules is "complex coacervationt' which is commercially the most common for pressure-sensitive copy paper. In this process, two colloidal substances, such as gelatin and an anionic polymeric substance, having mutually opposite electric charges, are added to a cor~-containing sUspens ~ ~orm , ..
~,: - 1 --, : .: :-: :, ~. ,:, - : -. ~ . . . ,, ;: , -.: . , ,,,- , : , ~322133 an aqueous sol, which is then pH-adjusted or otherwise treated to form a wall of coacervates on the microdroplets of an oily core material, and after they have gelled the coacervates are hardened with a hardening agent to form microcapsules. Details of this complex coacervation process are disclosed in U.S. Patent No. 2,800,457, etc. and many methods of improvement have been proposed.
For instance, Japanese Patent Publication No. 39-24782 proposes that the temperature of the system be slowly elevated in the presence of a hardening reagent in order to shorten the duration of the hardening treatment. Japanese Patent Publication Nos. 47-16166, 47-16167 and 47-16168 propose that in order to prevent agglomeration of coacer-vates, an anti-shock agent be added after the wall membrane of coacervates has been gelled. Japanese Patent Publica-tion Nos~ 50-27827, 50-27828 and 50-27829 show that by adding an anti-shock agent such as CMC or an acrylic acid copolymer together with an anionic surfactant, it is possible to prevent any increase in viscosity that would otherwise occur on account of the reaction taking place between gelatin and aldehyde during the pre-hardening step. Japanese Patent Public Disclosure No. 61-4527 discloses a method in which a water-soluble wax derivative is added after gelation and before hardening. Methods employing hardening agents that may be added to foods are disclosed in Japanese Patent Public Disclosure ~os. 59-36540, 60-37934, 61-4527, 61-78351, etc.
-, . .:
~322133 As described above, numerous improvements have been developed in the technology of microencapsulation by complex coacervation. However, there still remains much room for improvement in the art of hardening coacervates. For 5 example, no process has yet been developed for producing ;~
mi.crocapsules employing a hardening a~ent which can be safely incorporated in foodstuffs, which is stable, and -which allows the hardening treatment to be effected within a short period. Hardening agents that are most commonly employed in the conventional techniques of complex coacerva-tion are aldehydes such as formaldehyde and glutaraldeh~de.
~owever, aldehydes are toxic and cannot be used in the production of mlcrocapsules to be incorporated in foodstuffs.
A further problem with the use of aldehydes as hardeners is tha~t the pH of~the system has to be adjusted to the alkali s~ide~in order to~increase the rate of hardening reaction. Unless utmost cars ~lS exerclsed in the pH
adjustment, agglomeration of coacervates and other troubles wiIl occur to increase the~complexity of process control.
Hardeners that have been employed in the production of microcapsules for~incorporation in foodstuffs include .
glucono delta lactone, tannic acid, potassium alum [KAl(S 04 ) 2 12H20] and arnrnonium alum [NH4Al(SO4)2 12H~O].
Glucono delta lactone and~tannic acid harden gelatin by causing acid denaturation of the gelatin~protein, and the alum compounds achieve the same result by binding between the molecules of gelatin protein. However, all of these - 1`3-2`27~`3 3 hardeners are slow in their hardening rate because their action is weaker than that of aldehydes. If the reaction temperature is raised in an attempt of increase the hardening rate, the chance coacervates of being broken is increased. Under these circumstances, the hardening reaction must be carried out over a prolonged period ~usually several tens of hours) at room temperature.
Furthermore, the ~Yall membrane of the resulting capsules is weak and has insufficient heat resistance.
Summary of the Invention The present invention has been accomplished in order to solve the aforementioned problems of the prior art and its principal object is to ~rovide a method of hardening coacervates in the production of microcapsules i) in a pH
range that will not cause a~glomeration of the coacervates ii) within a short period of time iii) without employing any harmful component that cannot be incorporated in foodstuffs and by which iv)~microcapsules having high physical strength and heat resistance can be obtained.
This object of the present invention can be attained by a process for produclng microcapsules by complex coacervation of an aqueous solution of gelatin and an anionic polymeric substance having a core material present in an emulsified or dispersed state, ~Yhich is characteri~ed in that the gelatin in the wall membrane of coacervates formed around the microdroplets o~ the core material is hardened by crosslinking reaction ~ith a iridoid compound so as to produce microcapsules.
,:
`- i3221~3 Detailed Description of the Invention The present inventors found that iridoid compounds, in particular genipin, are a very effective hardeners for use in the production of microcapsules having a gelatin wall S membrane.
The present invention provides a process for producing microcapsules b~r complex coacervation o-f an aqueous solution of ~elatin and an anionic polymeric substance having a core material present in an emulsified or dispersed state, ~hich is characterized in that the gelatin in the wall membrane of coacervates formed around the microdroplets of the core material is hardened by crosslinking reaction wlth a ilidoid compound so as to produce microcapsules.
The first step of the process of the present invention is to have the core material emulsified or dlspersed in an aqueous solution containing gelatin and an anionic polymer. This may be accomplished b~ mixing an aqueous solution of an anionic polymer with an aqueous gelatin solution that has the core material emulsified or dispersed in it. Alternatively? the core material emulsified or dispersed in the aqueous solution of an anionic polymer may be mixed with the aqueous gelatin solution. Still another approach is to have the core material emulsified or dispersed in an aqueous solution containin~ gelatin and an anionic polymer. In short, the first step o~ the process of the present invention is satisfactorily performed if the core material is emulsified :.: ., . : :~ :
~ ~ , :. :-, . ..
: . :: , - . :
~322~
or dispersed in an aqueous solution containing gelatin and an anionic polymer.
A suitable core material may be selected from among oily substances such as flavor oils and lecithin, and from water-insoluble solid particles such as stearyl alcohol.
There is no particular limitation on the gelatin that can be used but it is preferable to use gelatin having good physicochemical and chemical properties as typi-fied by good film-forming ability, the nature of an ampholyte, the controllability of the quantity of charges by pH, and the occurrence of the change from sol to gel at a critical temperature. Stated specifically, any gelatin that satisfies the specifications for use in the production of a certain microcapsule may be employed. More preferably, gelatin ha~ing an isoelectric point of pH ~ - 9 and a bloom strength of 280 - 320 is used.
Any anionic polymer that reacts with gelatin to ~orm complex coacervates may be employed and preferred examples include gum arabic, sodium alginate, agar, carrageenan, carboxymethyl cellulose, sodium polyacrylate, polyphosphoric acid, etc.
The mixture of gelatin and a suitable anionic polymer is diluted with war~ water; thereafter, an acidic aqueous solution such as acetic acid is added to reduce the pH of the system to the isoelectrie pOillt of gelatin or below, and the mixture is stirred with the temperature elevated at least to the gelling point of gelatin. In this step, coacervates will form. The p~ of the reaction system is :
1~2~3 normally reduced to between 4.0 and 5.0 but this condition need not be satisfied if the pH is no higher than the isoelectric point of the gelatin used. The temperature of the system is usuallY adjusted to be ~ithin the range of 45 - 55C.
The coacervates are then cooled to 20C or below to gel and are thereafter subjected to a hardening reaction.
What is important to the process of the present invention is that a iridoid compound is used as a hardening agent.
Stated more specifically, a iridoi~compound is added to a coacervate-containing slurry and the temperature of the system is slowly elevated to effect the hardenlng reaction.
In this step, the gelatin component o$ the coacervates is hardened to become water-insoluble, thereby completing the production of microcapsules having the core material conflned in the shell of coacervates.
Any i~idoid compound having a crosslinking ability may be used in the process of the present invention and illustrative examples are the a~lycones of geniposide, gardenoside, geniposidic acid, etc. Of these compounds, genipin derived from Gardenia jasminoides Ellis which is the aglycone of genlposide is most preferred. These iridoid compounds may be prepared in accordance with the disclosures in Japanese Patent Publication r~O. 57-14781, Japanese Patent Public Disclosure~No. 61-47167, etc.
The amount of the lridoid compound to be used in the hardening reaction ranges from 0.001 to 1.0 part per part of gelatin on a dry weight basis. In accordance with the - . -`` ~322~33 process of the present invention, the amount of iridoid co~pound used may be adjusted to control the physical properties and heat stability of the microcapsules to be obtained, thereby making it possible to produce microcapsules of a desired strength.
The hardening reaction is preferably conducted at a pH of ~ - 10, more preferablY below 7 where agglomeration of coacervates will not easily ta~e place. One of the great advantage o-f the present invention is that the coacervates can be hardened within this preférred range of pH. The reaction temperature may be ~ithin the range of 5 - 60C.
Since the iridoid compounds have a comparatively strong cross-linking action, the intended hardening reaction can be accomplished without further eleva-ting the temperature. The re.action time varies with pH andAtemperature~ but a satisfactory hardening treatment can be performed by leaving the system to stand or stirring it for a period o~ 0.5 - 2 hours.
It has been reported that the iridoid compounds derived from Gardenia jasminoides Ellis which are used as hardeners in the process of the present invention react with primary amino compounds and are further polymerized under oxidizing conditions to form blue dyes (Japanese Patent Publication No. 57-14781 and Japanese Patent Public Disclosure No. 61-47167). The safety of the ~lue dyes thus formed has been widely recognized as a result of their extensive use as natural pigments in foods. Therefore, the microcapsules produced in the process of the present ~e:
~ , ,., . : ".
- :. , .~ - :, . , : - ,., :
, : . ~ ~. . , :,: , . . . .
. :,- : " :i , - :
1322~3'~
invention by crosslinking a iridold compound with complex coacervates of gelatin and an anionic pol~mer are also safe and are of particularly utility for use in foods, pharmaceuticals and other fields of industry.
s The following examples are provided for the purpose of further illustrating the present invention but are in no way to be taken as limiting.
ExamPle 1 ~;~
Peppermint oiI (9 g) was dispersed and emulsi-fied, with stirring, in 30 g of a 10% aqueous solution of ~elatin ~ype A) at 40C to form an oil-in-water~(0/W) emulsion. To the resulting emulsion, 30 g of a 10% aqueous gum arabic solution preheated to 40C was added with stirring. To the llquid mixture, 140 g of warm~water (40-C) was added, followed by addition of acetic acid to adJust the pH of the system to 4Ø The system was quickly quenched to 10C with -stirring. Thereafter. 3 g of genipin was added to~the system while at the same tlme, its~pH was adjusted to 6.0 with sodium hydroxide.~ Subsequently, a hardening treatment was conducted by raising the temperature of the system to 40C ~t a rate of 1C/min. The precipitated microcapsules were thoroughly washed with water to remove any uncrosslinked genipln and thereafter centrifuged for 10 minutes at 2,800 rpm to recover the microcapsules as~the final product.
Example 2 A cold (10C) microcapsule solution was prepared as .
in Example 1. To the system was added 3 g of genipin and ~, . ~ .
~` _ g _ .
~32~133 the resulting system having a pH of 4.0 was subjected to a hardening treatment for 18 hours at 20C under mild stirring. The precipitated microcapsules were washed thoroughly with water to remove any uncrosslinked genipin and thereafter centrifuged for 10 minutes at 2,800 rpm to recover the microcapsules as the final product.
ExamPle 3 Microcapsules were produced by the same procedures of microencapsulation as those adapted in Example 2 except that the amount of genipin was reduced to 0.3 g.
Example 4 Microcapsules were produced by the same procedures of microencapsulation as those adapted ln Example 2 except that the amount of genipin was further reduced to 0.03 g.
The microcapsules produced in Examples 1 - 4 were suitable for use as peppermint flavors in ready-to-eat foods.
Comparative ExamDle 1 ~
~ A cold (10C) microcapsule solution was prepared as in Example 1. Three grams of glucono delta lactone was added to the solution under stirring and a hardening treatment was then performed by mildly stirring the ~ixture at 20~C for 18 hours. The precipitated microcapsules were washed thoroughly with water and centri~uged at 2,800 rpm for 10 minutes to recover the microcapsules as the final product.
Comparative Example 2 - : : - -: :: . : . : . :. :
13221~3 Microcapsules were produced as in Comparative Example 1 except that 3 g of potassium alum was used as a hardener.
Comparative Example 3 Microcapsules were produced as in Comparative Example 1 except that 3 g of tannic acid was used as a hardener.
Comparative Test The microcapsules produced in Examples 1 - 4 and Comparative Examples 1 - 3 were dried, and 5 g of each sample was added to 100 ml of distilled water. The solution were heated at a rate of 1C/min and the temperature at which the wall of microcapsules in each sample thoroughly dissolved was measured. The results are shown in Table l;
the wall of the microcapsules in the samples of Examples 1 and 2 dlssolved at lOO C and that of the microcapsules in the sample of Example 3 dissolved at 80C; in contrast, wall dissolution occurred at 45C and below in the samples o-f Example 4 and Comparatlve Examples 1 - 3.
These results show that by h~ardenin~ coacervates with genipin, the heat resisitance of microcapsules was improved, the duration of hardening treatment was shortened (see Example 1), and the degree of heat resistance could be controlled by adjusting the~amount of genipin added.
Table 1 also shows the amount of agglomeration which occurred in the microcapsules of Examples 1 - 4 and Com-parative Examples 1 -~3 after centrifugation. No detectable agglomeration occurred in the samples produced in Examples 1 - 4, but the wall membranes of the capsules prepared in Comparative Examples 1 - 3 were so weak that they readily , 132~133 formed agglomeration materials. It is therefore clear that the hardening treatment ~ith genipin is also effective in improving the handling properties of microcapsules.
Table 1 Evaluation of the Heat Stability of Microcapsules and Their Agglomeration after Centrifu~ation Capsule melting Agglomeration of SamPle No~ _ temperature Cmicrocavsules 10Example 1 100 Comparative 15Example 1 35 ++
2 40 - +-~
3 45 +
-: No agglomeration +: Some agglomeration ~+: Extensive agglomeration The present invention pro~ides a process for producing microcapsules by complex coacervation using gelatin as at least one hydrophlic colloid. In this process, a iridoid compound having no human toxicit~ which can be safely incorporated in foodstuffs is used as a hardener for coacervates. Besides the advantage o-f rapidity of treatment, the iridoid compound is capable of hardening coacervates with reduced agglomeration, thereby enabling the desired microcapsules to be produced easily and efficiently.
If desired, an appropriate degree of heat resistance can be imparted to the microcapsules, so they have potential use in a wide range of applications including the food and pharmaceutical industries.
~ : , . ...
Claims (4)
1. In a process for producing microcapsules by complex coacervation of an aqueous solution of gelatin and an anionic polymeric substance having a core material present in an emulsified or dispersed state, the improvement wherein the gelatin in the wall membrane of coacervates formed around the microdroplets of the core material is hardened by crosslinking reaction with a iridoid compound to produce microcapsules.
2. A process according to Claim 1 wherein the iridoid compound is used in an amount of 0.001 - 1.0 part per part of gelatin on a dry weight basis.
3. A process according to Claim 1 wherein the hardening reaction is performed at a pH of 4 - 10 and at a temperature of 5 - 60°C.
4. A process according to Claim 1, 2 or 3, wherein said iridoid compound is genipin.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62093645A JPS63258641A (en) | 1987-04-16 | 1987-04-16 | Manufacture of microcapsules |
CA000587965A CA1322133C (en) | 1987-04-16 | 1989-01-11 | Process for producing microcapsules |
US07/296,777 US5023024A (en) | 1987-04-16 | 1989-01-13 | Process for producing microcapsules |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62093645A JPS63258641A (en) | 1987-04-16 | 1987-04-16 | Manufacture of microcapsules |
CA000587965A CA1322133C (en) | 1987-04-16 | 1989-01-11 | Process for producing microcapsules |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1322133C true CA1322133C (en) | 1993-09-14 |
Family
ID=25672371
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA000587965A Expired - Fee Related CA1322133C (en) | 1987-04-16 | 1989-01-11 | Process for producing microcapsules |
Country Status (3)
Country | Link |
---|---|
US (1) | US5023024A (en) |
JP (1) | JPS63258641A (en) |
CA (1) | CA1322133C (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63258641A (en) * | 1987-04-16 | 1988-10-26 | Suntory Ltd | Manufacture of microcapsules |
JPH02107163A (en) * | 1988-10-15 | 1990-04-19 | Suntory Ltd | Production of novel gelatinous food |
JPH02107162A (en) * | 1988-10-15 | 1990-04-19 | Suntory Ltd | Gelatinization of emulsified material |
US5200191A (en) * | 1991-09-11 | 1993-04-06 | Banner Gelatin Products Corp. | Softgel manufacturing process |
US5759599A (en) * | 1992-03-30 | 1998-06-02 | Givaudan Roure Flavors Corporation | Method of flavoring and mechanically processing foods with polymer encapsulated flavor oils |
US5536513A (en) * | 1992-03-30 | 1996-07-16 | Tastemaker | Flavored flour containing allium oil capsules and method of making flavored flour dough product |
US5552149A (en) * | 1993-10-12 | 1996-09-03 | Lignotech Usa, Inc. | Method for microencapsulation of agriculturally active substances |
US6039901A (en) * | 1997-01-31 | 2000-03-21 | Givaudan Roure Flavors Corporation | Enzymatically protein encapsulating oil particles by complex coacervation |
US6139886A (en) * | 1999-03-19 | 2000-10-31 | General Mills, Inc. | R-T-E cereals with calcium containing pre-sweetener coating and method of preparation |
US6174553B1 (en) | 1999-03-19 | 2001-01-16 | General Mills, Inc. | R-T-E cereals with calcium containing pre-sweetener coating and method of preparation |
US6210720B1 (en) | 1999-09-22 | 2001-04-03 | General Mills, Inc. | Calcium fortified cereal product and method of preparation |
CA2408015A1 (en) * | 2000-05-05 | 2001-11-15 | General Mills, Inc. | Food products fortified with calcium and method of preparation |
US6562361B2 (en) | 2001-05-02 | 2003-05-13 | 3M Innovative Properties Company | Pheromone immobilized in stable hydrogel microbeads |
US20040032036A1 (en) * | 2002-08-19 | 2004-02-19 | Anandaraman Subramaniam | Process for the preparation of flavor or fragrance microcapsules |
CN100456951C (en) * | 2003-05-28 | 2009-02-04 | 荷兰联合利华有限公司 | Satiety enhancing food products |
EP1633212B1 (en) * | 2003-05-28 | 2010-01-06 | Unilever N.V. | Satiety enhancing food products |
WO2005014698A1 (en) * | 2003-08-08 | 2005-02-17 | Mcmaster University | Methods for the preparation of cross-linked polymer networks using coacervation and in situ cross-linking |
US8828134B2 (en) | 2005-04-28 | 2014-09-09 | Flexiblast Pty Ltd. | Pressure impulse mitigation |
WO2007009023A2 (en) * | 2005-07-13 | 2007-01-18 | Engineered Release Systems, Inc. | Chemically cross-linked elastomeric microcapsules |
WO2008042970A2 (en) * | 2006-10-03 | 2008-04-10 | Haggard Warren O | Chitosan-coated calcium sulfate based medicament delivery system |
US8663690B2 (en) * | 2006-10-31 | 2014-03-04 | William Marsh Rice University | Method for nanoencapsulation |
EP2062985A1 (en) | 2007-11-23 | 2009-05-27 | N-Zyme BioTec GmbH | Method and device for tanning hides and pelts |
CA2799818A1 (en) * | 2010-05-24 | 2011-12-01 | University Of Utah Research Foundation | Reinforced adhesive complex coacervates and methods of making and using thereof |
BR112013006381B1 (en) * | 2010-09-20 | 2024-02-15 | Spi Pharma Inc | COMPOSITION COMPRISING A CORE MATERIAL HAVING A TASTE VALUE AND A POLYMERIC COATING AND PHARMACEUTICAL FORMULATION |
EP2926894A1 (en) * | 2014-03-31 | 2015-10-07 | Givaudan SA | Improvements in or relating to organic compounds |
KR102218427B1 (en) * | 2017-09-20 | 2021-02-22 | 차의과학대학교 산학협력단 | Coacervate composition comprising protein drug and wound healing agent comprising the same |
WO2019092049A1 (en) * | 2017-11-07 | 2019-05-16 | Royal College Of Surgeons In Ireland | A thermo-responsive hydrogel for intratumoral administration as a treatment in solid tumor cancers |
WO2019118444A1 (en) * | 2017-12-13 | 2019-06-20 | The University Of Massachusetts | Crosslinked particles, composition comprising the crosslinked particles, method for the manufacture thereof, and method of treating an infection |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3582495A (en) * | 1968-01-29 | 1971-06-01 | Ncr Co | Treatment of hydrophilic polymeric capsule wall material with vanadium compounds |
US3627695A (en) * | 1969-05-05 | 1971-12-14 | Ncr Co | Insolubilization of gelatin-containing film by citrate treatment |
US3944502A (en) * | 1970-08-06 | 1976-03-16 | Fuji Photo Film Co., Ltd. | Process for preparing microcapsules containing hydrophobic oil drops |
DE2911192A1 (en) * | 1979-03-22 | 1980-10-02 | Boehringer Sohn Ingelheim | INNOVATIVE IMMOBILIZED GLUCOSE OXIDASE CATALASE PREPARATION AND ITS USE FOR ENZYMATIC GLUCOSE OXIDATION |
JPS5952417B2 (en) * | 1979-06-22 | 1984-12-19 | 富士写真フイルム株式会社 | Silver halide photographic material |
JPS58149645A (en) * | 1982-03-01 | 1983-09-06 | Ajinomoto Co Inc | Preparation of gelatinized material |
WO1984003054A1 (en) * | 1983-02-02 | 1984-08-16 | Memtec Ltd | Cross linked porous membranes |
JPS6357981A (en) * | 1986-08-28 | 1988-03-12 | 株式会社 栗本鉄工所 | Method of removing iron group unnecessary buried pipe |
US4775745A (en) * | 1986-12-08 | 1988-10-04 | National Distillers And Chemical Corporation | Diazonium compounds useful as components for nucleic acid probes |
JPS63258641A (en) * | 1987-04-16 | 1988-10-26 | Suntory Ltd | Manufacture of microcapsules |
JPS6423861A (en) * | 1987-07-17 | 1989-01-26 | Suntory Ltd | Gelatinous food |
JPS6423860A (en) * | 1987-07-17 | 1989-01-26 | Suntory Ltd | Soft capsule |
-
1987
- 1987-04-16 JP JP62093645A patent/JPS63258641A/en active Pending
-
1989
- 1989-01-11 CA CA000587965A patent/CA1322133C/en not_active Expired - Fee Related
- 1989-01-13 US US07/296,777 patent/US5023024A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPS63258641A (en) | 1988-10-26 |
US5023024A (en) | 1991-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1322133C (en) | Process for producing microcapsules | |
US4402856A (en) | Microcapsules with a defined opening temperature, a process for their production and their use | |
US3539465A (en) | Encapsulation of hydrophilic liquid-in-oil emulsions | |
US3043782A (en) | Process for preparing a more impermeable coating by liquid-liquid phase separation | |
US4409156A (en) | Process for producing microcapsules | |
US3190837A (en) | Making individual capsules by dual deposition | |
US4157983A (en) | Process for production of encapsulated water-dispersible materials | |
US3748277A (en) | Process of forming minute capsules | |
US4356108A (en) | Encapsulation process | |
US4138362A (en) | Formation of microcapsules by interfacial cross-linking, microcapsules produced, and microcapsular dispersion | |
US4273672A (en) | Microencapsulation process | |
US4025455A (en) | Cross-linked hydroxypropylcellulose microcapsules and process for making | |
US4681806A (en) | Particles containing releasable fill material and method of making same | |
KR100305338B1 (en) | Method for fabricating microparticles in emulsion by modification of the chemical composition of the dispersed phase after emulsification | |
US5225118A (en) | Process for manufacturing polyurea microcapsules and product therefrom | |
US4162165A (en) | Process for the production of microcapsular coating compositions containing pigment particles and compositions produced thereby | |
JPS5812055B2 (en) | Method for curing capsules containing hydrophobic oil droplets | |
US5919407A (en) | Method for producing microencapsulated adhesive | |
US3993831A (en) | Microcapsules, process for their formation and transfer sheet record material coated therewith | |
US5270446A (en) | Decolorized crosslinked products and method for decolorization of crosslinked products | |
US3533958A (en) | Process for making minute capsules | |
KR20160140635A (en) | Improvements in or relating to organic compounds | |
DE10104841A1 (en) | Capsule-in-capsule system and method for its production | |
EP0820346B1 (en) | Microencapsulation process | |
US3804775A (en) | Method of preparing microcapsules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MKLA | Lapsed |